A proof-of-concept clinical trial of the norovirus (virus-like particle (VLP) plus rotavirus VP6 non-live injectable adjuvant-free vaccine for the prevention of acute gastroenteritis in children.
Phase of Trial: Phase I
Latest Information Update: 14 Feb 2012
At a glance
- Drugs Norovirus and rotavirus vaccine (Primary)
- Indications Norovirus infections; Rotavirus infections
- Focus Pharmacodynamics
- Sponsors UMN Pharma
- 14 Feb 2012 Trial is planned to be initiated in 2012, according to an UMN Pharma media release.
- 14 Feb 2012 New trial record